NCT01706575 / 2012-000080-25: A Study of Pegasys (Peginterferon Alfa-2a) Added to Nucleos(t)Ide Analogue Treatment in Participants With HBeAg-Negative Chronic Hepatitis B Genotype D Showing Stable Hepatitis B Virus (HBV) Deoxyribonucleic Acid (DNA) Suppression |
|
|
| Completed | 2b | 76 | Europe | Pegylated Interferon (Peginterferon) Alfa-2a, Pegasys, Nucleos(t)ide Analogues (NA) | Hoffmann-La Roche | Hepatitis B, Chronic | 09/13 | 11/14 | | |
ROCO2, NCT00221650: Treatment of Chronic Hepatitis C With PEG Interferon alfa2a and Ribavirin in HIV-Infected Patients |
|
|
| Completed | 2 | 17 | Europe | Peginterferon alfa2a, Ribavirin | University Hospital, Bordeaux, Hoffmann-La Roche, Ministry of Health, France | HIV Infections, Hepatitis C, Chronic, Treatment Failure | | 06/04 | | |
NCT00148863: Interferon Gamma With Peg-Interferon Alpha 2a and Ribavirin in Non Responders Patients With Chronic Hepatitis C |
|
|
| Completed | 2 | 65 | Europe | Peg-interferon alpha 2a (drug), Ribavirin (drug), Interferon gamma (drug) | French National Agency for Research on AIDS and Viral Hepatitis, InterMune, Hoffmann-La Roche | Hepatitis C, Chronic | | 08/07 | | |
